38 results
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Osimertinib #NSCLC ... #Survival #NEJM
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Summary of Major Clinical ... Trials - EGDT: NEJM ... - ProCESS: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Non–Small-Cell Lung Cancer #EBM ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Major Clinical Trials ... Thresholds in Critical ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... /vmoitra) #EBM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
New Vertebral, Clinical ... Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM
Centor - Clinical Decision Rule for Management of Sore Throat #Diagnosis #Management #EM #IM #Centor #Criteria
Centor - Clinical ... Diagnosis #Management #EM ... #IM #Centor #Criteria
Cullen Sign Pancreatitis #Clinical #EM #IM #Cullen #Pancreatiis #Sign #PhysicalExam
Pancreatitis #Clinical ... #EM #IM #Cullen